Michael Specht
Private Equity Investor at 3i Deutschland Gesellschaft für Industriebeteiligungen mbH
Network origin in Michael Specht first degree
Entity | Entity type | Industry | |
---|---|---|---|
3i Deutschland Gesellschaft für Industriebeteiligungen mbH
3i Deutschland Gesellschaft für Industriebeteiligungen mbH Investment ManagersFinance 3i Deutschland Gesellschaft für Industriebeteiligungen mbH (3i Deutschland) is the German private equity subsidiary of 3i Group Plc (LSE: III) in Great Britain. Established in Frankfurt in 1984, the firm invests in small and medium-sized German companies at all stages of development, from start-ups to established businesses. In addition to the Frankfurt office, 3i Deutschland has offices in Munich and Stuttgart. They drive their investment focus and decisions from their Frankfurt and Munich offices, and the team collaborates with Swiss colleagues in Zurich and 3i's network across Europe, Asia and the U.S. to invest in a wide range of industry sectors.
17
| Subsidiary | Investment Managers | 17 |
Warburg Pincus International LLC
13
| Subsidiary | Investment Managers | 13 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Specht via their personal network
Company | Sector | Related people | Main position |
---|---|---|---|
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
DEUTSCHE BANK AG | Investment Banks/Brokers | Corporate Officer/Principal Private Equity Analyst | |
3I GROUP PLC | Investment Managers | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Helsinn Healthcare SA
Helsinn Healthcare SA Pharmaceuticals: MajorHealth Technology Helsinn Healthcare SA develops and provides licenses for drugs. The firm offers services to oncology, cancer supportive care, pain and inflammation, gastrointestinal fields. The company was founded by Gabriele Braglia in 1976 and is headquartered in Pazzallo, Switzerland. | Pharmaceuticals: Major | Director/Board Member | |
LGT Capital Partners AG
LGT Capital Partners AG Investment ManagersFinance LGT Capital Partners AG (LGT Capital Partners) is a venture capital subsidiary of LGT Holding International AG founded in 1997 by Thomas Weber. The firm is headquartered in Pfäffikon, Switzerland. | Investment Managers | Private Equity Investor | |
University of Oxford | College/University | Graduate Degree | |
Imperial College London | College/University | Undergraduate Degree | |
Maastricht University | College/University | Undergraduate Degree | |
INVESTCORP HOLDINGS B.S.C. | Investment Managers | Corporate Officer/Principal | |
Singular Bank SA
Singular Bank SA Investment Banks/BrokersFinance Singular Bank SA, also known as Self Bank, is a bank that helps individuals take control of their finances. The company is based in Madrid, Spain, and has subsidiaries in Italy, Luxembourg, Spain, Cayman Islands, and Portugal. The Spanish company offers free Visa cards with no commissions and free withdrawals from any ATM worldwide. The bank provides a free alert service for added security and offers various investment products that can be traded through a Cuenta Bolsa account. The company was founded in 1966, and Javier Marin Romano has been the CEO since 2019. | Investment Banks/Brokers | Chairman Director/Board Member | |
Kyowa Kirin International Plc
Kyowa Kirin International Plc Pharmaceuticals: MajorHealth Technology Kyowa Kirin International Plc is a specialty pharmaceutical company, which engages in the development and commercialization of prescription medicines for the treatment of unmet therapeutic needs in major markets. It offers Sancuso, a prescription medicine used to prevent nausea and vomiting in people receiving some types of chemotherapy treatment and Abstral, a medicine used in the management of breakthrough pain in adult patients using opioid therapy for chronic cancer pain. The company was founded in 1995 and is headquartered in Galashiels, the United Kingdom. | Pharmaceuticals: Major | Director/Board Member | |
St. Edward's University | College/University | Masters Business Admin | |
University of Bristol | College/University | Undergraduate Degree Graduate Degree | |
Copenhagen Business School | College/University | Undergraduate Degree | |
London School of Economics & Political Science | College/University | Graduate Degree Graduate Degree | |
University College London | College/University | Undergraduate Degree | |
RWTH Aachen University | College/University | Doctorate Degree | |
University of Hagen | College/University | Undergraduate Degree | |
Universität Paderborn | College/University | Doctorate Degree | |
Heinrich-Heine-Universität Düsseldorf | College/University | Undergraduate Degree | |
OULA FUEL MARKETING COMPANY - KSCP | Oil Refining/Marketing | Director/Board Member | |
European Federation of Pharmaceutical Industries & Assns
European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Italfarmaco SpA
Italfarmaco SpA Pharmaceuticals: MajorHealth Technology Italfarmaco SpA engages in the production and distribution of pharmaceutical and fine chemical products. It also provides research and development, scientific publishing, business development, and licensing services. The company was founded in 1938 and is headquartered in Milan, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Fraunhofer-Gesellschaft eV
Fraunhofer-Gesellschaft eV Miscellaneous Commercial ServicesCommercial Services Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. operates as an application-oriented research organization. The firm focuses on health, security, communication, as well as environment and energy. It develops technology, designs products, and improves methods and techniques. The company was founded on March 26, 1949 and is headquartered in Munich, Germany. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Quanta Dialysis Technologies Ltd.
Quanta Dialysis Technologies Ltd. Medical SpecialtiesHealth Technology Quanta Dialysis Technologies Ltd. develops haemodialysis systems. The firm's SC+ is a performance, portable, compact haemodialysis system providing clinical efficacy utilising flow rates typically used on traditional machines. It offers SelfCare+, a haemodialysis machine for dialysis patients to control their disease and determine the treatment regime and care. The company was founded by Clive Henrey Buckberry, John Eric Milad and Martin Johnson in 2008 and is headquartered in Alcester, the United Kingdom. | Medical Specialties | Director/Board Member | |
NORMA GROUP SE | Industrial Machinery | Director/Board Member | |
Helsinn Holding SA
Helsinn Holding SA Hospital/Nursing ManagementHealth Services Helsinn Holding SA is a holding Swiss company that provides cancer services through its subsidiaries. The private company is based in Lugano, Switzerland and has subsidiaries in Switzerland and Ireland. The company was founded in 1976 by Gabriele Edoardo Braglia. Riccardo Braglia has been the CEO of the company since 2002. | Hospital/Nursing Management | Director/Board Member | |
BSP Pharmaceuticals SpA
BSP Pharmaceuticals SpA Pharmaceuticals: MajorHealth Technology BSP Pharmaceuticals SpA develops and manufactures anticancer drugs. It offers development, clinical supply, commercial supply, and analytical services. The company was founded by Aldo Braca in July 2006 and is headquartered in Latina Scalo, Italy. | Pharmaceuticals: Major | Director/Board Member | |
Pharmacia & Upjohn SpA | Corporate Officer/Principal | ||
Directorbank Executive Search Ltd.
Directorbank Executive Search Ltd. Other Consumer ServicesConsumer Services The Directorbank Group Ltd. provides executive employment placement services. Its consultants offer their clients with ongoing support and bespoke targeted search services. The firm's clients include major global buyout houses, mid-market private equity firms and venture capital enterprises. Its practice areas include business services, consumer, TMT, CFO, healthcare, industrial, financial services. The company was founded in 1998 and is headquartered in London, the United Kingdom. | Other Consumer Services | Director/Board Member | |
Cell Therapy Ltd.
Cell Therapy Ltd. BiotechnologyHealth Technology Cell Therapy Ltd. produces regenerative medicines using adult stem cells to treat heart failure. Its product HeartCel, a stem cell therapy that offers improved outcomes for heart failure patients by reducing the size of heart scar, improving heart function, quality of life and reducing mortality. The firm develops therapies based on the adult mesenchymal stromal cells technology platform. The firm’s regenerative therapies will focus on curing the cause of the disease, rather than only treating the symptoms. The company was founded in 2009 by Martin John Evans and Ajan Trevor Reginald and is headquartered in Cardiff, the United Kingdom. | Biotechnology | Director/Board Member | |
Rotterdam School of Management | College/University | Graduate Degree | |
SDA Bocconi School of Management | College/University | Masters Business Admin | |
NIOX GROUP PLC | Medical/Nursing Services | Chairman | |
PAI Partners SL
PAI Partners SL Investment ManagersFinance PAI Partners provides equity investment services. The firm invests in Sectors that include business services, food and consumer goods, general industrials, healthcare and retail and distribution. The company is headquartered in Madrid, Spain. | Investment Managers | Private Equity Investor | |
Helsinn Healthcare SA /Venture/
Helsinn Healthcare SA /Venture/ Investment ManagersFinance 3B FUTURE HEALTH VENTURES SARL (3B Future Health Ventures) is a venture capital subsidiary of Helsinn Healthcare SA founded in 2016. The firm is headquartered in Monaco, Luxembourg. | Investment Managers | Private Equity Investor | |
FSI SGR SpA
FSI SGR SpA Investment ManagersFinance FSI SGR SpA (FSI) also known as Fondo Strategico Italiano, is an independent private equity firm. The firm was founded in 2016 and is headquartered in Milan, Italy. | Investment Managers | Private Equity Investor | |
Micromega Ltd.
Micromega Ltd. Miscellaneous Commercial ServicesCommercial Services Micromega Ltd. provides business support services. The private company is based in London, UK. The British company was founded by Francesco Granata. | Miscellaneous Commercial Services | Founder | |
Diadem SpA
Diadem SpA Miscellaneous Commercial ServicesCommercial Services Diadem Srl predicts, monitors, diagnosis and drug development for Alzheimer?s disease. focuses on specific research on early peripheral markers of Alzheimer's disease into technology. The company was founded by Maurizio Memo and Daniela Uberti in June 2012 and is headquartered in Brescia, Italy. | Miscellaneous Commercial Services | Director/Board Member | |
UTILITY therapeutics Ltd.
UTILITY therapeutics Ltd. Pharmaceuticals: GenericHealth Technology Utility Therapeutics Ltd. is a British company that has exclusive US commercial rights to two European-approved antibiotics, mecillinam and an oral prodrug of mecillinam, for the treatment of urinary tract infections (UTI). The private company is based in Altrincham, UK and was founded in 2018 by Rasmus Toft-Kehler, Morten Otto Alexander Sommer, Peter Aksel Villadsen. Mecillinam is being developed as a first-line therapy for complicated UTI in the hospital setting, while the oral prodrug is being developed for uncomplicated UTI. The company has received the FDA's Qualified Infectious Disease Product (QIDP) designation for the treatment of UTI. Utility Therapeutics is committed to developing antibiotics that meet urgent treatment needs for multi-drug resistant infections. | Pharmaceuticals: Generic | Director/Board Member | |
Preservation Capital Partners Ltd.
Preservation Capital Partners Ltd. Investment ManagersFinance Preservation Capital Partners Ltd (Preservation Capital) is an independent private equity firm founded in 2017. The firm is headquartered in London. | Investment Managers | Founder | |
College of Law-York | College/University | Undergraduate Degree |
Statistics
International
United Kingdom | 17 |
Germany | 7 |
Italy | 7 |
United States | 6 |
Switzerland | 4 |
Sectoral
Consumer Services | 17 |
Finance | 11 |
Health Technology | 10 |
Commercial Services | 6 |
Health Services | 3 |
Operational
Director/Board Member | 58 |
Private Equity Investor | 30 |
Corporate Officer/Principal | 28 |
Undergraduate Degree | 18 |
Chairman | 14 |
Most connected contacts
- Stock Market
- Insiders
- Michael Specht
- Company connections